These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 8504286

  • 1. Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance.
    Slinkin MA, Curtet C, Faivre-Chauvet A, Sai-Maurel C, Gestin JF, Torchilin VP, Chatal JF.
    Nucl Med Biol; 1993 May; 20(4):443-52. PubMed ID: 8504286
    [Abstract] [Full Text] [Related]

  • 2. Site-specific conjugation of chain-terminal chelating polymers to Fab' fragments of anti-CEA mAb: effect of linkage type and polymer size on conjugate biodistribution in nude mice bearing human colorectal carcinoma.
    Slinkin MA, Curtet C, Sai-Maurel C, Gestin JF, Torchilin VP, Chatal JF.
    Bioconjug Chem; 1992 May; 3(6):477-83. PubMed ID: 1463777
    [Abstract] [Full Text] [Related]

  • 3. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments.
    Narula J, Petrov A, Bianchi C, Ditlow CC, Lister BC, Dilley J, Pieslak I, Chen FW, Torchilin VP, Khaw BA.
    Circulation; 1995 Aug 01; 92(3):474-84. PubMed ID: 7634463
    [Abstract] [Full Text] [Related]

  • 4. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice.
    Buchegger F, Haskell CM, Schreyer M, Scazziga BR, Randin S, Carrel S, Mach JP.
    J Exp Med; 1983 Aug 01; 158(2):413-27. PubMed ID: 6886623
    [Abstract] [Full Text] [Related]

  • 5. Direct comparison of a radioiodinated intact chimeric anti-CEA MAb with its F(ab')2 fragment in nude mice bearing different human colon cancer xenografts.
    Vogel CA, Bischof-Delaloye A, Mach JP, Pèlegrin A, Hardman N, Delaloye B, Buchegger F.
    Br J Cancer; 1993 Oct 01; 68(4):684-90. PubMed ID: 8398694
    [Abstract] [Full Text] [Related]

  • 6. Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments.
    Yazaki PJ, Wu AM, Tsai SW, Williams LE, Ikler DN, Wong JY, Shively JE, Raubitschek AA.
    Bioconjug Chem; 2001 Oct 01; 12(2):220-8. PubMed ID: 11312683
    [Abstract] [Full Text] [Related]

  • 7. Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen.
    Karacay H, Sharkey RM, McBride WJ, Griffiths GL, Qu Z, Chang K, Hansen HJ, Goldenberg DM.
    Bioconjug Chem; 2002 Oct 01; 13(5):1054-70. PubMed ID: 12236788
    [Abstract] [Full Text] [Related]

  • 8. Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.
    Buchegger F, Pfister C, Fournier K, Prevel F, Schreyer M, Carrel S, Mach JP.
    J Clin Invest; 1989 May 01; 83(5):1449-56. PubMed ID: 2708519
    [Abstract] [Full Text] [Related]

  • 9. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
    Jakowatz JG, Beatty BG, Vlahos WG, Porudominsky D, Philben VJ, Williams LE, Paxton RJ, Shively JE, Beatty JD.
    Cancer Res; 1985 Nov 01; 45(11 Pt 2):5700-6. PubMed ID: 4053043
    [Abstract] [Full Text] [Related]

  • 10. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G, Buchegger F, Waibel R, Kuenzi G, Offord RE, Schubiger PA, Gillet M, Delaloye AB.
    Cancer Biother Radiopharm; 2001 Oct 01; 16(5):371-9. PubMed ID: 11776754
    [Abstract] [Full Text] [Related]

  • 11. Tumor targeting and pharmacokinetics of unmodified and modified F(ab)2 fragments of an anti-CEA murine monoclonal antibody (Immu-14).
    Siddiqui A, Quadri SM, Griffiths GL, Goldenberg DM, Vriesendorp HM.
    Nucl Med Biol; 1995 May 01; 22(4):425-35. PubMed ID: 7550018
    [Abstract] [Full Text] [Related]

  • 12. Comparative biodistribution and radioimmunotherapy of monoclonal antibody RS7 and its F(ab')2 in nude mice bearing human tumor xenografts.
    Stein R, Blumenthal R, Sharkey RM, Goldenberg DM.
    Cancer; 1994 Feb 01; 73(3 Suppl):816-23. PubMed ID: 8306265
    [Abstract] [Full Text] [Related]

  • 13. Selection of a DTPA chelate conjugate for monoclonal antibody targeting to a human colonic tumor in nude mice.
    Sharkey RM, Motta-Hennessy C, Gansow OA, Brechbiel MW, Fand I, Griffiths GL, Jones AL, Goldenberg DM.
    Int J Cancer; 1990 Jul 15; 46(1):79-85. PubMed ID: 2114375
    [Abstract] [Full Text] [Related]

  • 14. Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts.
    Sharkey RM, Motta-Hennessy C, Pawlyk D, Siegel JA, Goldenberg DM.
    Cancer Res; 1990 Apr 15; 50(8):2330-6. PubMed ID: 2180566
    [Abstract] [Full Text] [Related]

  • 15. Enhanced clearance of radiolabeled murine monoclonal antibody by a syngeneic anti-idiotype antibody in tumor-bearing nude mice.
    Sharkey RM, Boerman OC, Natale A, Pawlyk D, Monestier M, Losman MJ, Goldenberg DM.
    Int J Cancer; 1992 May 08; 51(2):266-73. PubMed ID: 1568794
    [Abstract] [Full Text] [Related]

  • 16. Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy.
    Behr TM, Memtsoudis S, Sharkey RM, Blumenthal RD, Dunn RM, Gratz S, Wieland E, Nebendahl K, Schmidberger H, Goldenberg DM, Becker W.
    Int J Cancer; 1998 Aug 31; 77(5):787-95. PubMed ID: 9688314
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
    Molthoff CF, Pinedo HM, Schlüper HM, Nijman HW, Boven E.
    Br J Cancer; 1992 May 31; 65(5):677-83. PubMed ID: 1586596
    [Abstract] [Full Text] [Related]

  • 18. Radiolabeled monoclonal antibody 15 and its fragments for localization and imaging of xenografts of human lung cancer.
    Endo K, Kamma H, Ogata T.
    J Natl Cancer Inst; 1988 Aug 03; 80(11):835-42. PubMed ID: 3392743
    [Abstract] [Full Text] [Related]

  • 19. Significance of circulatory clearance of tumour-localising IgG and F(ab')2 for potential therapy studied in a CEA-producing xenograft model.
    Harwood PJ, Pedley RB, Boden J, Rogers GT.
    Tumour Biol; 1987 Aug 03; 8(1):19-25. PubMed ID: 3602844
    [Abstract] [Full Text] [Related]

  • 20. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
    Burvenich IJ, Schoonooghe S, Blanckaert P, Bacher K, Vervoort L, Coene E, Mertens N, De Vos F, Slegers G.
    Nucl Med Biol; 2007 Apr 03; 34(3):257-65. PubMed ID: 17383575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.